Federal Register / Vol. 62, No. 234 / Friday, December 5, 1997 / Notices 64393

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Center

for Scientific Review Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Clinical Sciences.

Date: December 4, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4104,

Telephone Conference.

Contact Person: Dr. Priscilla Chen,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4104, Bethesda,

Maryland 20892, (301) 435–1787.

Name of SEP: Microbiological and

Immunological.

Date: December 11, 1997.

Time: 1:30 p.m.

Place: NIH, Rockledge 2, Room 5112,

Telephone Conference.

Contact Person: Dr. Gilbert Meier,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5112, Bethesda,

Maryland 20892, (301) 435–1169.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Chemistry and Related

Sciences.

Date: December 2, 1997.

Time: 11:30 a.m.

Place: NIH, Rockledge 2, Room 4172,

Telephone Conference.

Contact Person: Dr. Donald Schneider,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4172, Bethesda,

Maryland 20892, (301) 435–1727.

This notice is being published less

than 15 days prior to the above meetings

due to the urgent need to meet timing

limitations imposed by the grant review

and funding cycle.

The meetings will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: December 1, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–31830 Filed 12–4–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

This Notice is now available on the

internet at the following website: http:/

/www.health.org

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, Room

13A–54, 5600 Fishers Lane, Rockville,

Maryland 20857; Tel.: (301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratory, 8901 W. Lincoln Ave., West

Allis, WI 53227, 414–328–7840 (formerly:

Bayshore Clinical Laboratory)

Aegis Analytical Laboratories, Inc., 345 Hill

Ave., Nashville, TN 37210, 615–255–2400

Alabama Reference Laboratories, Inc., 543

South Hull St., Montgomery, AL 36103,

800–541–4931 / 334–263–5745

Alliance Laboratory Services, 3200 Burnet

Ave., Cincinnati, OH 45229, 513–569–2051

(formerly: Jewish Hospital of Cincinnati,

Inc.)

American Medical Laboratories, Inc., 14225

Newbrook Dr., Chantilly, VA 22021, 703–

802–6900

Associated Pathologists Laboratories, Inc.,

4230 South Burnham Ave., Suite 250, Las

Vegas, NV 89119–5412, 702–733–7866 /

800–433–2750

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–583–

2787 / 800–242–2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little Rock,

AR 72205–7299, 501–202–2783 (formerly:

Forensic Toxicology Laboratory Baptist

Medical Center)

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5784

Clinical Reference Lab, 8433 Quivira Rd.,

Lenexa, KS 66215–2802, 800–445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle Park,

NC 27709, 919–572–6900 / 800–833–3984

(Formerly: CompuChem Laboratories, Inc.,

A Subsidiary of Roche Biomedical

Laboratory, Roche CompuChem

Laboratories, Inc., A Member of the Roche

Group)

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson Ave.,

Springfield, MO 65802, 800–876–3652 /

417–269–3093 (formerly: Cox Medical

Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P.O. Box 88–

6819, Great Lakes, IL 60088–6819, 847–

688–2045 / 847–688–4171

Diagnostic Services Inc., dba DSI, 4048 Evans

Ave., Suite 301, Fort Myers, FL 33901,

941–418–1700 / 800–735–5416